Integral Health Asset Management, LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Integral Health Asset Management, LLC disclosed 63 US equity positions worth $849.4m in its Q3 2024 13F filing. The largest position was INSM at 12.5% of the reported book, followed by THC and BSX.
What did Integral Health Asset Management, LLC own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | INSM INSMED INC | Healthcare | 12.5% | $105.8m | 1,450,000 | – | |
| 2 | THC TENET HEALTHCARE CORP | Healthcare | 10.4% | $88.1m | 530,000 | – | |
| 3 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 5.4% | $46.1m | 550,000 | – | |
| 4 | CYTK CYTOKINETICS INC | Healthcare | 4.7% | $39.6m | 750,000 | – | |
| 5 | LONGBOARD PHARMACEUTICALS IN | 4.1% | $35.0m | 1,050,000 | – | ||
| 6 | INSP INSPIRE MED SYS INC | Healthcare | 4.0% | $33.8m | 160,000 | – | |
| 7 | MDT MEDTRONIC PLC | Healthcare | 3.2% | $27.0m | 300,000 | – | |
| 8 | 2655787D BLUEPRINT MEDICINES CORP | 3.2% | $26.8m | 290,000 | – | ||
| 9 | EHC ENCOMPASS HEALTH CORP | Healthcare | 3.1% | $26.6m | 275,000 | – | |
| 10 | NVS NOVARTIS AG | Healthcare | 2.7% | $23.0m | 200,000 | – | |
| 11 | ACLXGBX ARCELLX INC | 2.7% | $23.0m | 275,000 | – | ||
| 12 | MRK MERCK & CO INC | Healthcare | 2.7% | $22.7m | 200,000 | – | |
| 13 | VERA VERA THERAPEUTICS INC | Healthcare | 2.6% | $22.1m | 500,000 | – | |
| 14 | DGX QUEST DIAGNOSTICS INC | Healthcare | 2.2% | $18.6m | 120,000 | – | |
| 15 | NARIUSD INARI MED INC | 1.9% | $16.5m | 400,000 | – | ||
| 16 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.9% | $15.9m | 350,000 | – | |
| 17 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 1.8% | $15.3m | 300,000 | – | ||
| 18 | RGNX REGENXBIO INC | Healthcare | 1.6% | $13.4m | 1,275,000 | – | |
| 19 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 1.5% | $12.3m | 375,000 | – | |
| 20 | COO COOPER COS INC | Healthcare | 1.4% | $12.1m | 110,000 | – | |
| 21 | KROS KEROS THERAPEUTICS INC | Healthcare | 1.4% | $11.6m | 200,000 | – | |
| 22 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 1.3% | $11.1m | 220,000 | – | |
| 23 | FMS FRESENIUS MEDICAL CARE AG | Healthcare | 1.1% | $9.6m | 450,000 | – | |
| 24 | BRKR BRUKER CORP | Healthcare | 1.1% | $9.3m | 135,000 | – | |
| 25 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 1.1% | $9.1m | 175,000 | – | |
| 26 | LLY ELI LILLY & CO | Healthcare | 1.0% | $8.9m | 10,000 | – | |
| 27 | DXCM DEXCOM INC | Healthcare | 0.9% | $8.0m | 120,000 | – | |
| 28 | CATALYST PHARMACEUTICALS INC | 0.9% | $8.0m | 400,000 | – | ||
| 29 | SANA SANA BIOTECHNOLOGY INC | Healthcare | 0.9% | $7.5m | 1,800,000 | – | |
| 30 | TFX TELEFLEX INCORPORATED | Healthcare | 0.9% | $7.4m | 30,000 | – | |
| 31 | BTSG BRIGHTSPRING HEALTH SVCS INC | Healthcare | 0.9% | $7.3m | 500,000 | – | |
| 32 | CRSP CRISPR THERAPEUTICS AG | Healthcare | 0.8% | $7.0m | 150,000 | – | |
| 33 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 0.8% | $6.9m | 25,000 | – | |
| 34 | APLT APPLIED THERAPEUTICS INC | 0.8% | $6.8m | 800,000 | – | ||
| 35 | JSPR JASPER THERAPEUTICS INC | 0.8% | $6.6m | 350,000 | – | ||
| 36 | TNDM TANDEM DIABETES CARE INC | Healthcare | 0.7% | $6.4m | 150,000 | – | |
| 37 | BNTX BIONTECH SE | Healthcare | 0.7% | $5.9m | 50,000 | – | |
| 38 | QDEL QUIDELORTHO CORP | Healthcare | 0.7% | $5.7m | 125,000 | – | |
| 39 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 0.7% | $5.7m | 250,000 | – | |
| 40 | EVH EVOLENT HEALTH INC | Healthcare | 0.7% | $5.7m | 200,000 | – | |
| 41 | EXK EXACT SCIENCES CORP | Basic Materials | 0.6% | $5.4m | 80,000 | – | |
| 42 | IQV IQVIA HLDGS INC | Healthcare | 0.6% | $4.7m | 20,000 | – | |
| 43 | TNYA TENAYA THERAPEUTICS INC | 0.5% | $4.6m | 2,375,000 | – | ||
| 44 | TWST TWIST BIOSCIENCE CORP | Healthcare | 0.5% | $4.5m | 100,000 | – | |
| 45 | NRIX NURIX THERAPEUTICS INC | Healthcare | 0.5% | $4.5m | 200,000 | – | |
| 46 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 0.5% | $4.3m | 356,000 | – | |
| 47 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 0.5% | $4.1m | 1,000,000 | – | |
| 48 | RVTY REVVITY INC | Healthcare | 0.5% | $3.8m | 30,000 | – | |
| 49 | ETNBGBP 89BIO INC | 0.4% | $3.7m | 500,000 | – | ||
| 50 | MYGN MYRIAD GENETICS INC | Healthcare | 0.4% | $3.4m | 125,000 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.